Immunoblotting analysis revealed that levels of 14-3-3ξ\δ proteins, important scaffold proteins that prevent bcl2 family member-induced apoptosis [28], decreased in T-ALL cells after MLN4924 treatment (Figure 8A). The gene discussed is BCL2; the disease is acute lymphoblastic leukemia.